VEEV Rasio silihan jangka dawa marang modal veeva.com

Veeva Systems Inc. (VEEV) dominates the pharmaceutical software sector due to the deep integration of its CRM systems into drug trial regulations. The cloud-based storage of critical data allows the company to flexibly manage subscription pricing. Price dynamics history on GURU.Markets shows that this metric is 0.02. The business is currently expanding its reach by implementing its platforms into the cosmetics and chemical segments to reduce industry dependence.

This ratio measures the proportion of long-term liabilities within the equity structure, allowing investors to assess the degree of financial leverage and the business's resilience to long-term credit risks. Analyzing the current long-term debt-to-equity ratio confirms the exceptional reliability of Veeva Systems Inc. (VEEV), whose impeccable reputation in biopharmaceuticals and strict adherence to regulatory standards guarantee a stable inflow of capital.